Limitation of polymyxin B on suppression of endotoxin shock induced by Salmonella infection in mice.
暂无分享,去创建一个
[1] H. Brade,et al. Endotoxin in Health and Disease , 2020 .
[2] B. Beutler,et al. Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.
[3] Takafumi Yoshikawa,et al. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. , 2004, Biological & pharmaceutical bulletin.
[4] Y. Kumazawa,et al. Time- and dose-dependent effect of fosfomycin on suppression of infection-induced endotoxin shock in mice. , 2002, Biological & pharmaceutical bulletin.
[5] Shigenori Tanaka,et al. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice? , 2002, Journal of endotoxin research.
[6] Shigenori Tanaka,et al. Differential clearance and induction of host responses by various administered or released lipopolysaccharides , 2001, Journal of endotoxin research.
[7] T. Calandra,et al. Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria1 , 2001, The Journal of Immunology.
[8] R. Ulevitch. New therapeutic targets revealed through investigations of innate immunity , 2001, Critical care medicine.
[9] A. Aderem,et al. Toll-like receptors in the induction of the innate immune response , 2000, Nature.
[10] B. Beutler,et al. Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. , 2000, European cytokine network.
[11] E. Davidson. ENDOTOXIN IN HEALTH AND DISEASE , 2000 .
[12] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[13] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[14] Y. Adachi,et al. Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages , 1999 .
[15] K. Matsushima,et al. The molecular pathogenesis of endotoxic shock and organ failure. , 1999, Molecular medicine today.
[16] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[17] T. Tani,et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. , 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.
[18] Y. Kumazawa,et al. Difference in clearance of exogenously administered smooth-form LPS following host responses among normal, sensitized and LPS-tolerant mice , 1997 .
[19] D. Morrison,et al. Measurement of different types of endotoxin in murine plasma by pretreatment with alkaline reagent and kinetic chromogenic Limulus test , 1997 .
[20] S. Bucklin,et al. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia , 1995, Antimicrobial agents and chemotherapy.
[21] C. Galanos,et al. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice , 1991, Infection and immunity.
[22] B. Stocker,et al. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines , 1981, Nature.
[23] Y. Kumazawa,et al. Suppression of infection-induced endotoxin shock in mice by a citrus flavanone naringin. , 2004, Planta medica.
[24] B. Beutler. LPS in microbial pathogenesis: promise and fulfilment. , 2002, Journal of endotoxin research.